our purpose
Provision of human cells for biotechnology and biomedicine
Evercyte makes use of specialized human primary like cells for the development of relevant in vitro test systems that allow the standardization of pre-clinical models.
Moreover, our cells are vaulable and innovative cell factories for production of recombinant complex molecules or (targeting) extracellular vesicles for clinical applications.
our technology
Life span extension, reprogramming and gene editing
In order to circumvent the limitations of currently used cell models, Evercyte has focused on the establishment of continuously growing cell lines that show morphology and functions of the corresponding primary cells.
Additionally, reprogramming and gene editing methods are applied to provide our customers with cells that cover their needs.
our focus
Relevant in vitro test systems and extracellular vesicles
Evercyte has put a focus on isolation of mesenchymal stem cells from different tissues and establishment of production systems for extracellular vesicles, recombinant vesicles. Moreover, Evercyte aims to set up preclinical test systems that represent the human body and allow e.g. toxicity studies or the evaluation of the potency of compounds or exosomes.
our purpose
Provision of human cells for biotechnology and biomedicine
Evercyte makes use of specialized human primary like cells for the development of relevant in vitro test systems that allow the standardization of pre-clinical models. Moreover, our cells are ideal for use as innovative cell factories, for production of recombinant complex molecules or extracellular vesicles for
clinical applications.
our technology
Life span extension, reprogramming and gene editing
In order to circumvent the limitations of currently used cell models, Evercyte has focused on the establishment of continuously
growing cell lines that show functions of the corresponding primary cells. Additionally, reprogramming and gene editing methods are applied to provide our customers
with cells that cover their needs.
our focus
Relevant in vitro test systems and extracellular vesicles
Evercyte has put a focus on isolation of mesenchymal stromal cells from different tissues and establishment of production systems for extracellular vesicles, recombinant vesicles. Moreover, Evercyte aims to set up preclinical test systems that represent the human body and allow e.g. toxicity studies, potency assays or drug testing such as senolytic drugs.
products
products
services
services
customer reviews
“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”
Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.
“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform. We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”
Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.
latest news
Overexpression of green fluorescent protein in endothelial cells
Overexpression of green fluorescent protein in endothelial cells Application: establishment of reporter cell lines from relevant and standardizable telomerized
Scratch assay for monitoring skin cell proliferation / migration
Scratch assay for monitoring skin cell proliferation / migration screening for substances that induce fibroblast growth application: identification
Analysis of miRNA cargo of extracellular vesicles from Wharton´s Jelly derived mesenchymal stem cells
Analysis of miRNA cargo of extracellular vesicles from Wharton´s Jelly derived mesenchymal stem cells WJ-MSC/TERT273 application: characterization and
Study of myofibroblast differentiation
Study of myofibroblast differentiation monitoring the effect of exogenous factors on myofibroblast differentiation in a model using TGFß as inducer
3D spheroid assay for screening of angiogenesis modulators
3D spheroid assay for screening of angiogenesis modulators monitoring the effect of exogenous factors on sprout formation from endothelial spheroids
Testing for cytokine targeting
Testing for cytokine targeting screening for drugs targeting Interleukin-17A (Il-17A) using human fibroblasts that release IL-6 upon IL-17A treatment